(MedPage Today) — Note that some links may require registration or subscription. A preprint study flagged signals of frailty in seniors taking the GLP-1 drug tirzepatide (Zepbound) for weight loss. (Reuters via Yahoo!) The House passed a bill…
Source: MedPage Today — Headlines
